KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Novavax (NVAX) Other Gross PP&E Adjustments (2016 - 2025)

Novavax (NVAX) has 15 years of Other Gross PP&E Adjustments data on record, last reported at $46.8 million in Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 83.91% year-over-year to $46.8 million; the TTM value through Dec 2025 reached $46.8 million, up 83.91%, while the annual FY2025 figure was $46.8 million, 83.91% up from the prior year.
  • Other Gross PP&E Adjustments reached $46.8 million in Q4 2025 per NVAX's latest filing, up from $25.5 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $277.6 million in Q4 2022 and bottomed at -$108.7 million in Q3 2022.
  • Average Other Gross PP&E Adjustments over 5 years is $40.4 million, with a median of -$106000.0 recorded in 2021.
  • Peak YoY movement for Other Gross PP&E Adjustments: tumbled 102477.36% in 2022, then surged 83.91% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $186.7 million in 2021, then skyrocketed by 48.65% to $277.6 million in 2022, then tumbled by 31.62% to $189.8 million in 2023, then tumbled by 86.59% to $25.5 million in 2024, then soared by 83.91% to $46.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $46.8 million in Q4 2025, $25.5 million in Q4 2024, and $189.8 million in Q4 2023.